Inhibin immunohistochemical staining: A practical approach for the surgical pathologist in the diagnoses of ovarian sex cord-stromal tumors

Advances in Anatomic Pathology

Volumn 10, Issue 1, 2003, Pages 27-38

  Zheng, Wenxin ^a   Senturk, Billur Z ^a   Parkash, Vinita ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Granulosa; Inhibin; Leydig; Sertoli; Sex cord stromal tumor

Indexed keywords

INHIBIN; INHIBIN ALPHA SUBUNIT; INHIBIN-ALPHA SUBUNIT; TUMOR MARKER;

CHEMISTRY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; METHODOLOGY; OVARY TUMOR; PATHOLOGY; REVIEW; SEX CORD TUMOR;

FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBINS; OVARIAN NEOPLASMS; PATHOLOGY, SURGICAL; SEX CORD-GONADAL STROMAL TUMORS; TUMOR MARKERS, BIOLOGICAL;

EID: 1842844672     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/00125480-200301000-00003     Document Type: Review

References (91)

1. McCullagh DR. Dual endocrine activity of the testis. Science 1932;76:19-20.
2. Setchell BP, Jacks F. Inhibin-like activity in rete testis fluid. J Endocrinol 1974;62:675-676.
3. Franchimont P, Millet D, Vendrely E, Letawe J, Legros JJ, Netter A. Relationship between spermatogenesis and serum gonadotropin levels in azoospermia and oligospermia. J Clin Endocrinol Metab 1972;34:1003-1008.
4. Keogh EJ, Lee VW, Rennie GC, Burger HG, Hudson B, De Kretser DM. Selective suppression of FSH by testicular extracts. Endocrinology 1976;98:997-1004.
5. De Jong FH, Sharpe RM. Evidence for inhibin-like activity in bovine follicular fluid. Nature 1976;263:71-72.
6. Ling N, Ying SY, Ueno N, Esch F, Denoroy L, Guillemin R. Isolation and partial characterization of a Mr 32,000 protein with inhibin activity from porcine follicular fluid. Proc Natl Acad Sci USA 1985;82:7217-7221. (Pubitemid 16193713)
7. Vale W, Rivier J, Vaughan J, et al. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 1986;321:776-779. (Pubitemid 16077904)
8. LaPolt PS, Hsueh AJW. Molecular basis of inhibin production and action. Mol Cell Neurosci 1991;2:449-463.
9. Matzuk MM, Finegold MJ, Su JG, Hsueh AJ, Bradley A. Alpha-inhibin is a tumor-suppressor gene with gonadal specificity in mice. Nature 1992;360:313-319. (Pubitemid 23000668)
10. Di Simone N, Crowley WF Jr., Wang QF, Sluss PM, Schneyer AL. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation. Endocrinology 1996;137:486-494. (Pubitemid 26049884)
11. Shikone T, Matzuk MM, Perlas E, et al. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor. Mol Endocrinol 1994;8:983-995. (Pubitemid 24254006)
12. Flemming P, Wellmann A, Maschek H, Lang H, Georgii A. Monoclonal antibodies against inhibin represent key markers of adult granulosa cell tumors of the ovary even in their metastases. A report of three cases with late metastasis, being previously misinterpreted as hemangiopericytoma. Am J Surg Pathol 1995;19:927-933.
13. Zheng W, Sung CJ, Hanna I, Lambert-Messerlian G, Steinhoff M, Lauchlan SC. Alpha and beta subunits of inhibin/activin as sex cord-stromal differentiation markers. Int J Gynecol Pathol 1997;16:263-271. (Pubitemid 27282301)
14. Rishi M, Howard LN, Bratthauer GL, Tavassoli FA. Use of monoclonal antibody against human inhibin as a marker for sex cordstromal tumors of the ovary. Am J Surg Pathol 1997;21:583-589. (Pubitemid 27213074)
15. Gurusinghe CJ, Healy DL, Jobling T, Mamers P, Burger HG. Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue. Gynecol Oncol 1995;57:27-32.
16. McCluggage WG, Sloan JM, Murnaghan M, White R. Gynandroblastoma of ovary with juvenile granulosa cell component and heterologous intestinal type glands. Histopathology 1996;29:253-257. (Pubitemid 26302734)
17. Arora DS, Cooke IE, Ganesan TS, et al. Immunohistochemical expression of inhibin/activin subunits in epithelial and granulosa cell tumors of the ovary. J Pathol 1997;181:413-418. (Pubitemid 27223527)
18. Costa MJ, Ames PF, Walls J, Roth LM. Inhibin immunohistochemistry applied to ovarian neoplasms: a novel, effective, diagnostic tool. Hum Pathol 1997;28:1247-1254. (Pubitemid 27492823)
19. Mulvany NJ, Riley CB. Granulosa cell tumors of unilocular cystic type. Pathology 1997;29:348-353. (Pubitemid 27515486)
20. Stewart CJ, Jeffers MD, Kennedy A. Diagnostic value of inhibin immunoreactivity in ovarian gonadal stromal tumors and their histologic mimics. Histopathology 1997;31:67-74. (Pubitemid 27314508)
21. Hildebrandt RH, Rouse RV, Longacre TA. Value of inhibin in the identification of granulosa cell tumors of the ovary. Hum Pathol 1997;28:1387-1395. (Pubitemid 28013635)
22. McCluggage WG, Maxwell P, Sloan JM. Immunohistochemical staining of ovarian granulosa cell tumors with monoclonal antibody against inhibin. Hum Pathol 1997;28:1034-1038. (Pubitemid 27388104)
23. McCluggage WG, Shanks JH, Whiteside C, Maxwell P, Banerjee SS, Biggart JD. Immunohistochemical study of testicular sex cordstromal tumors, including staining with antiinhibin antibody. Am J Surg Pathol 1998;22:615-619. (Pubitemid 28213749)
24. Matias-Guiu X, Pons C, Prat J. Mullerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors. Hum Pathol 1998;29:840-845. (Pubitemid 28375991)
25. Matias-Guiu X, Prat J. Alpha-inhibin immunostaining in diagnostic pathology. Adv Anat Pathol 1998;5:263-267.
26. Pelkey TJ, Frierson HF Jr., Mills SE, Stoler MH. The diagnostic utility of inhibin staining in ovarian neoplasms. Int J Gynecol Pathol 1998;17:97-105. (Pubitemid 28151006)
27. Riopel MA, Perlman EJ, Seidman JD, Kurman RJ, Sherman ME. Inhibin and epithelial membrane antigen immunohistochemistry assist in the diagnosis of sex cord-stromal tumors and provide clues to the histogenesis of hypercalcemic small cell carcinomas. Int J Gynecol Pathol 1998;17:46-53. (Pubitemid 28016702)
28. Schnittger C, Soudah B, von Wasielewski R, et al. Infiltration of the central nervous system by a granulosa cell tumor immunostained by antibodies against inhibin. Neurology 1998;50:560-562. (Pubitemid 28119818)
29. Wells M. Making sense of inhibin in ovarian tumors. Histopathology 1998;32:81-83.
30. Kommoss F, Oliva E, Bhan AK, Young RH, Scully RE. Inhibin expression in ovarian tumors and tumor-like lesions: an immunohistochemical study. Mod Pathol 1998;11:656-664. (Pubitemid 28335144)
31. Guerrieri C, Franlund B, Malmstrom H, Boeryd B. Ovarian endometrioid carcinomas simulating sex cord-stromal tumors: a study using inhibin and cytokeratin 7. Int J Gynecol Pathol 1998;17:266-271. (Pubitemid 28299742)
32. McCluggage WG, Maxwell P. Adenocarcinomas of various sites may exhibit immunoreactivity with anti- inhibin antibodies. Histopathology 1999;35:216-220.
33. Zheng W, Lauchlan SC. Inhibin and activin: their roles in ovarian tumorigenesis and their diagnostic utility in surgical pathology practice. Appl Immunohistochem Mol Morphol 1999;7:29-38. (Pubitemid 29190268)
34. Woodruff TK. Role of inhibins and activins in ovarian cancer. Cancer Treat Res 2002;107:293-302.
35. Wallace EM, Healy DL. Inhibins and activins: roles in clinical practice. Br J Obstet Gynaecol 1996;103:945-956. (Pubitemid 26340163)
36. Lambert-Messerlian GM. Is inhibin a serum marker for ovarian cancer? Europ J Endocrinol 2000;142:331-333. (Pubitemid 30230756)
37. Mason AJ, Hayflick JS, Ling N, et al. Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-beta. Nature 1985;318:659-663. (Pubitemid 16172414)
38. Vale W, Rivier C, Hsueh A, et al. Chemical and biologic characterization of the inhibin family of protein hormones. Recent Prog Horm Res 1988;44:1-34.
39. Dye RB, Rabinovici J, Jaffe RB. Inhibin and activin in reproductive biology. Obstet Gynecol Surv 1992;47:173-185.
40. Findlay JK. An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis. Biol Reprod 1993;48:15-23. (Pubitemid 23005206)
41. Matzuk MM, Kumar TR, Shou W, et al. Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development. Recent Prog Horm Res 1996;51:123-154. (Pubitemid 126476612)
42. Ying SY. Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev 1988;9:267-293.
43. Cobellis L, Cataldi P, Reis FM, et al. Gonadal malignant germ cell tumors express immunoreactive inhibin/activin subunits. Eur J Endocrinol 2001;145:779-784. (Pubitemid 33133686)
44. Robertson DM, Hayward S, Irby D, et al. Radioimmunoassay of rat serum inhibin: changes after PMSG stimulation and gonadectomy. Mol Cell Endocrinol 1988;58:1-8.
45. Puls LE, Hamous J, Morrow MS, Schneyer A, MacLaughlin DT, Castracane VD. Recurrent ovarian sex cord tumor with annular tubules: tumor marker and chemotherapy experience. Gynecol Oncol 1994;54:396-401. (Pubitemid 24301922)
46. Jobling T, Mamers P, Healy DL, et al. A prospective study of inhibin in granulosa cell tumors of the ovary. Gynecol Oncol 1994;55:285-289. (Pubitemid 24366640)
47. Ohashi M, Hasegawa Y, Haji M, Igarashi M, Nawata H. Production of immunoreactive inhibin by a virilizing ovarian tumor (Sertoli-Leydig tumor). Clin Endocrinol 1990;33:613-618. (Pubitemid 20346609)
48. Healy DL, Burger HG, Mamers P, et al. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. N Engl J Med 1993;329:1539-1542. (Pubitemid 23332439)
49. Lappohn RE, Burger HG, Bouma J, Bangah M, Krans M, de Bruijn HW. Inhibin as a marker for granulosa-cell tumors. N Engl J Med 1989;321:790-793. (Pubitemid 19237426)
50. Sluijmer AV, Heineman MJ, Evers JL, de Jong FH. Peripheral vein, ovarian vein and ovarian tissue levels of inhibin in a postmenopausal patient with a granulosa cell tumor. Acta Endocrinol 1993;129:311-314. (Pubitemid 23319222)
51. Groome NP, Illingworth PJ, O'Brien M, et al. Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay. Clin Endocrinol 1994;40:717-723. (Pubitemid 24216620)
52. Groome NP, Illingworth PJ, O'Brien M, et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 1996;81:1401-1405. (Pubitemid 26119665)
53. Scully RE, Yong RH, Clement PB. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligment. Atlas of tumor pathology. Fascicle 23, 3rd series. Washington, DC: Armed Forces Institute of Pathology; 1998:6-7.
54. Gaffey MJ, Frierson HF Jr., Iezzoni JC, et al. Ovarian granulosa cell tumors with bizarre nuclei: an immunohistochemical analysis with fluorescence in situ hybridization documenting trisomy 12 in the bizarre component [corrected]. Mod Pathol 1996;9:308-315.
55. Gitsch G, Kohlberger P, Hanzal E, Kolbl H, Breitenecker G. Immunohistochemical differentiation between ovarian granulosa cell tumors and ovarian carcinomas. Arch Gynecol Obstet 1991;249:173-177.
56. Benjamin E, Law S, Bobrow LG. Intermediate filaments cytokeratin and vimentin in ovarian sex cord-stromal tumors with correlative studies in adult and fetal ovaries. J Pathol 1987;152:253-263. (Pubitemid 17126713)
57. Aguirre P, Thor AD, Scully RE. Ovarian small cell carcinoma. Histogenetic considerations based on immunohistochemical and other findings. Am J Clin Pathol 1989;92:140-149. (Pubitemid 19187691)
58. Costa MJ, DeRose PB, Roth LM, Brescia RJ, Zaloudek CJ, Cohen C. Immunohistochemical phenotype of ovarian granulosa cell tumors: absence of epithelial membrane antigen has diagnostic value. Hum Pathol 1994;25:60-66. (Pubitemid 24051826)
59. Chadha S, van der Kwast TH. Immunohistochemistry of ovarian granulosa cell tumors. The value of tissue specific proteins and tumor markers. Virchows Arch A Pathol Anat Histopathol 1989;414:439-445. (Pubitemid 19121766)
60. Santini D, Ceccarelli C, Leone O, et al. Smooth muscle differentiation in normal human ovaries, ovarian stromal hyperplasia and ovarian granulosa-stromal cells tumors. Mod Pathol 1995;8:25-30.
61. McCluggage WG, Maxwell P. Immunohistochemical staining for calretinin is useful in the diagnosis of ovarian sex cord-stromal tumors. Histopathology 2001;38:403-408. (Pubitemid 32863015)
62. McCluggage WG. Value of inhibin staining in gynecological pathology. Int J Gynecol Pathol 2001;20:79-85. (Pubitemid 32041758)
63. McCluggage WG, Sloan JM, Boyle DD, Toner PG. Malignant fibrothecomatous tumor of the ovary: diagnostic value of antiinhibin immunostaining. J Clin Pathol 1998;51:868-871. (Pubitemid 28530856)
64. Zheng W, Luo MP, Welt C, et al. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer. Gynecol Oncol 1998;69:23-31. (Pubitemid 28201667)
65. Zheng W, Lu J, Luo F, et al. Tumor stroma as the main source of inhibin production in ovarian epithelial tumors. Am J Reprod Immunol 2000;44:104-113. (Pubitemid 30621333)
66. Roth LM, Liban E, Czernobilsky B. Ovarian endometrioid tumors mimicking Sertoli and Sertoli-Leydig cell tumors: Sertoliform variant of endometrioid carcinoma. Cancer 1982;50:1322-1331. (Pubitemid 12031956)
67. Young RH, Prat J, Scully RE. Ovarian endometrioid carcinomas resembling sex cord-stromal tumors. A clinicopathologic analysis of 13 cases. Am J Surg Pathol 1982;6:513-522. (Pubitemid 12029443)
68. Stevenson AJ, Chatten J, Bertoni F, et al. CD99 (p30/32MIC2) neuroectodermal Ewing's sarcoma antigen as an immunohistochemical marker: review of more than 600 tumors and the literature experience. Applied Immunohistochem 1994;2:231-240.
69. Ordi J, Schammel DP, Rasekh L, Tavassoli FA. Sertoliform endometrioid carcinomas of the ovary: a clinicopathologic and immunohistochemical study of 13 cases. Mod Pathol 1999;12:933-940. (Pubitemid 29485265)
70. Flemming P, Grothe W, Maschek H, Petry KU, Wellmann A, Georgii A. The site of inhibin production in ovarian neoplasms. Histopathology 1996;29:465-468. (Pubitemid 26384181)
71. Nucci MR, O'Connell JT, Huettner PC, Cviko A, Sun D, Quade BJ. h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors. Am J Surg Pathol 2001;25:455-463. (Pubitemid 32240884)
72. McCluggage WG. Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasms. J Clin Pathol 2000;53:327-334. (Pubitemid 30256898)
73. Young RH, Oliva E, Scully RE. Luteinized adult granulosa cell tumors of the ovary: a report of four cases. Int J Gynecol Pathol 1994;13:302-310. (Pubitemid 24309717)
74. Rush DS, Tan J, Baergen RN, Soslow RA. h-Caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma. Am J Surg Pathol 2001;25:253-258. (Pubitemid 32167508)
75. Kurman RJ, Norris HJ. Endodermal sinus tumor of the ovary: a clinical and pathologic analysis of 71 cases. Cancer 1976;38:2404-2419. (Pubitemid 8015876)
76. Prat J, Bhan AK, Dickersin GR, Robboy SJ, Scully RE. Hepatoid yolk sac tumor of the ovary (endodermal sinus tumor with hepatoid differentiation). A light microscopic, ultrastructural and immunohistochemical study of seven cases. Cancer 1982;50:2355-2368. (Pubitemid 13244172)
77. Young RH, Perez-Atayde AR, Scully RE. Ovarian Sertoli-Leydig cell tumor with retiform and heterologous components. Report of a case with hepatoid differentiation and elevated serum alpha-fetal protein. Am J Surg Pathol 1984;8:709-718. (Pubitemid 14068785)
78. Nogales FF, Concha A, Plata C, Riutz-Avila I. Granulosa cell of the ovary with diffuse true hepatic differentiation simulating stromal luteinization. Am J Surg Pathol 1993;17:85-90. (Pubitemid 23011325)
79. Devouassoux-Shisheboran M, Schammel DP, Tavassoli FA. Ovarian hepatoid yolk sac tumors: morphologic, immunohistochemical and ultrastructural features. Histopathology 1999;34:462-469. (Pubitemid 29244172)
80. Young RH, Oliva E, Scully RE. Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathologic analysis of 150 cases. Am J Surg Pathol 1994;18:1102-1116. (Pubitemid 24337617)
81. Ramzy I. Signet-ring stromal tumor of the ovary. Cancer 1976;38:166-172.
82. Suarez A, Palacios J, Burgos E, Camallo C. Signet-ring stromal tumor of the ovary: histochemical, immunohistochemical and ultrastructural study. Virchow's Arch Ann Pathol Anat 1993;422:333-336. (Pubitemid 23169380)
83. Dickersin GR, Young RH, Scully RE. Signet-ring stromal and related tumors of the ovary. Ultrastruc Pathology 1995;19:401-419.
84. Cashell AW, Jerome WG, Flores E. Signet ring stromal tumor of the ovary occurring in conjunction with brenner tumor. Gynecol Oncol 2000;77:323-326. (Pubitemid 30317159)
85. Ferry JA, Young RH, Engel G, Scully RE. Oxyphilic Sertoli cell tumor of the ovary: a report of three cases. Int J Gynecol Pathol 1994;13:259-266.
86. Young RH, Scully RE. Ovarian tumors of probable Wolffian origin. Am J Surg Pathol 1983;7:125-135.
87. Devouassoux-Shisheboran M, Silver SA, Tavassoli FA. Wolffian adnexal tumor, so-called femal adnexal tumor of probable wolffian origin (FATWO) immunohistochemical evidence in support of a wolffian origin. Human Pathol 1999;30:856-863. (Pubitemid 29325794)
88. Dubeau L. The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes? Gynecol Oncol 1999;72:437-442. (Pubitemid 29118208)
89. Doglioni C, Tos AP, Laurino L, Luzzolino P, Chiarelli C, Celio MR, Viale G. Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 1996;20:1037-1046. (Pubitemid 26276924)
90. Cao QJ, Jones JG, Li M. Expression of calretinin in human ovary, testis, and ovarian sex cord-stromal tumors. Intl J Gynecol Pathol 2001;20:346-352. (Pubitemid 32937449)
91. Movahedi-Lankarani S, Kurman RJ. Calretinin, a more sensitive but less specific marker than a-inhibin for ovarian sex cord-stromal and fibrous neoplasms: an immunohistochemical study of 206 cases. Mod Pathol 2002;15:203A.